These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1164 related articles for article (PubMed ID: 29802201)
1. The Hippo pathway effector proteins YAP and TAZ have both distinct and overlapping functions in the cell. Plouffe SW; Lin KC; Moore JL; Tan FE; Ma S; Ye Z; Qiu Y; Ren B; Guan KL J Biol Chem; 2018 Jul; 293(28):11230-11240. PubMed ID: 29802201 [TBL] [Abstract][Full Text] [Related]
2. A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis. Moroishi T; Park HW; Qin B; Chen Q; Meng Z; Plouffe SW; Taniguchi K; Yu FX; Karin M; Pan D; Guan KL Genes Dev; 2015 Jun; 29(12):1271-84. PubMed ID: 26109050 [TBL] [Abstract][Full Text] [Related]
3. Arterial Wall Stress Induces Phenotypic Switching of Arterial Smooth Muscle Cells in Vascular Remodeling by Activating the YAP/TAZ Signaling Pathway. Wang Y; Cao W; Cui J; Yu Y; Zhao Y; Shi J; Wu J; Xia Z; Yu B; Liu J Cell Physiol Biochem; 2018; 51(2):842-853. PubMed ID: 30466081 [TBL] [Abstract][Full Text] [Related]
4. The Hippo Pathway Prevents YAP/TAZ-Driven Hypertranscription and Controls Neural Progenitor Number. Lavado A; Park JY; Paré J; Finkelstein D; Pan H; Xu B; Fan Y; Kumar RP; Neale G; Kwak YD; McKinnon PJ; Johnson RL; Cao X Dev Cell; 2018 Dec; 47(5):576-591.e8. PubMed ID: 30523785 [TBL] [Abstract][Full Text] [Related]
5. Insights into the Regulation of Yap/Taz from Cellular Systems and Mouse Models. Du W; Du W; Wan M; Zhou X; Xu X; Zheng L Curr Stem Cell Res Ther; 2018; 13(1):16-25. PubMed ID: 28042766 [TBL] [Abstract][Full Text] [Related]
6. Transcriptional co-repressor function of the hippo pathway transducers YAP and TAZ. Kim M; Kim T; Johnson RL; Lim DS Cell Rep; 2015 Apr; 11(2):270-82. PubMed ID: 25843714 [TBL] [Abstract][Full Text] [Related]
7. YAP and TAZ Negatively Regulate Prox1 During Developmental and Pathologic Lymphangiogenesis. Cho H; Kim J; Ahn JH; Hong YK; Mäkinen T; Lim DS; Koh GY Circ Res; 2019 Jan; 124(2):225-242. PubMed ID: 30582452 [TBL] [Abstract][Full Text] [Related]
8. The Hippo Pathway Component TAZ Promotes Immune Evasion in Human Cancer through PD-L1. Janse van Rensburg HJ; Azad T; Ling M; Hao Y; Snetsinger B; Khanal P; Minassian LM; Graham CH; Rauh MJ; Yang X Cancer Res; 2018 Mar; 78(6):1457-1470. PubMed ID: 29339539 [TBL] [Abstract][Full Text] [Related]
9. Non-hippo kinases: indispensable roles in YAP/TAZ signaling and implications in cancer therapy. Zhu J; Wu T; Lin Q Mol Biol Rep; 2023 May; 50(5):4565-4578. PubMed ID: 36877351 [TBL] [Abstract][Full Text] [Related]
10. Physiological and pathological roles of the Hippo-YAP/TAZ signaling pathway in liver formation, homeostasis, and tumorigenesis. Nishina H Cancer Sci; 2022 Jun; 113(6):1900-1908. PubMed ID: 35349740 [TBL] [Abstract][Full Text] [Related]
11. The Hippo pathway effectors YAP and TAZ promote cell growth by modulating amino acid signaling to mTORC1. Hansen CG; Ng YL; Lam WL; Plouffe SW; Guan KL Cell Res; 2015 Dec; 25(12):1299-313. PubMed ID: 26611634 [TBL] [Abstract][Full Text] [Related]
12. A feed forward loop enforces YAP/TAZ signaling during tumorigenesis. Gill MK; Christova T; Zhang YY; Gregorieff A; Zhang L; Narimatsu M; Song S; Xiong S; Couzens AL; Tong J; Krieger JR; Moran MF; Zlotta AR; van der Kwast TH; Gingras AC; Sicheri F; Wrana JL; Attisano L Nat Commun; 2018 Aug; 9(1):3510. PubMed ID: 30158528 [TBL] [Abstract][Full Text] [Related]
13. Multifaceted regulation and functions of YAP/TAZ in tumors (Review). Liu H; Du S; Lei T; Wang H; He X; Tong R; Wang Y Oncol Rep; 2018 Jul; 40(1):16-28. PubMed ID: 29749524 [TBL] [Abstract][Full Text] [Related]
14. TAZ target gene ITGAV regulates invasion and feeds back positively on YAP and TAZ in liver cancer cells. Weiler SME; Lutz T; Bissinger M; Sticht C; Knaub M; Gretz N; Schirmacher P; Breuhahn K Cancer Lett; 2020 Mar; 473():164-175. PubMed ID: 31904487 [TBL] [Abstract][Full Text] [Related]
15. Hippo signalling governs cytosolic nucleic acid sensing through YAP/TAZ-mediated TBK1 blockade. Zhang Q; Meng F; Chen S; Plouffe SW; Wu S; Liu S; Li X; Zhou R; Wang J; Zhao B; Liu J; Qin J; Zou J; Feng XH; Guan KL; Xu P Nat Cell Biol; 2017 Apr; 19(4):362-374. PubMed ID: 28346439 [TBL] [Abstract][Full Text] [Related]
16. The Hippo pathway effectors TAZ/YAP regulate dicer expression and microRNA biogenesis through Let-7. Chaulk SG; Lattanzi VJ; Hiemer SE; Fahlman RP; Varelas X J Biol Chem; 2014 Jan; 289(4):1886-91. PubMed ID: 24324261 [TBL] [Abstract][Full Text] [Related]
17. [Regulation of differentiation of mesenchymal stem cells by the Hippo pathway effectors TAZ/YAP]. Men T; Piao SH; Teng CB Yi Chuan; 2013 Nov; 35(11):1283-90. PubMed ID: 24579311 [TBL] [Abstract][Full Text] [Related]
18. Cysteine S-Glutathionylation Promotes Stability and Activation of the Hippo Downstream Effector Transcriptional Co-activator with PDZ-binding Motif (TAZ). Gandhirajan RK; Jain M; Walla B; Johnsen M; Bartram MP; Huynh Anh M; Rinschen MM; Benzing T; Schermer B J Biol Chem; 2016 May; 291(22):11596-607. PubMed ID: 27048650 [TBL] [Abstract][Full Text] [Related]
19. Pro-invasive activity of the Hippo pathway effectors YAP and TAZ in cutaneous melanoma. Nallet-Staub F; Marsaud V; Li L; Gilbert C; Dodier S; Bataille V; Sudol M; Herlyn M; Mauviel A J Invest Dermatol; 2014 Jan; 134(1):123-132. PubMed ID: 23897276 [TBL] [Abstract][Full Text] [Related]
20. Metabolic control of YAP and TAZ by the mevalonate pathway. Sorrentino G; Ruggeri N; Specchia V; Cordenonsi M; Mano M; Dupont S; Manfrin A; Ingallina E; Sommaggio R; Piazza S; Rosato A; Piccolo S; Del Sal G Nat Cell Biol; 2014 Apr; 16(4):357-66. PubMed ID: 24658687 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]